Anastasia A. Kovpak

Long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against COVID-19 (CoviVac) in preclinical studies

Liubov I. Kozlovskaya, Anastasia N. Piniaeva, G. M. Ignatyev et al. · Emerging Microbes & Infections · 2021 · 76 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Isolation and phylogenetic analysis of SARS-CoV-2 variants collected in Russia during the COVID-19 outbreak

Liubov I. Kozlovskaya, Anastasia N. Piniaeva, G. M. Ignatyev et al. · International Journal of Infectious Diseases · 2020 · 51 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Vaccination With Oral Polio Vaccine Reduces COVID-19 Incidence

Nadezhda V. Yagovkina, K. A. Subbotina, Andrey A. Tsaan et al. · Frontiers in Immunology · 2022 · 39 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Structural characterization of <scp>β‐propiolactone</scp> inactivated severe acute respiratory syndrome coronavirus 2 (<scp>SARS‐CoV</scp>‐2) particles

Dmitry Bagrov, Andrey Moiseenko, Maria G. Karlova et al. · Microscopy Research and Technique · 2021 · 27 citations · Full text

Life Sciences, Biology, Infectious Diseases +17

Immunogenicity and Safety of Inactivated Sabin-Strain Polio Vaccine “PoliovacSin”: Clinical Trials Phase I and II

Anastasia N. Piniaeva, G. M. Ignatyev, Liubov I. Kozlovskaya et al. · Vaccines · 2021 · 21 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17